カテゴリ： MarketLine, アメリカ, 企業調査

Assertio Therapeutics Inc：企業の戦略・SWOT・財務分析

◆英語タイトル：Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4580
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report
Summary

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralgia caused by viral infection, herpes zoster, or nerve damage; management of mild to moderate acute pain in adults; migraine attacks in adults of 18 years of age or above; and pain in cancer patients of 18 years of age and older. The company sells its products to wholesale distributors and retail pharmacies. Assertio also licenses Acuform, its proprietary gastroretentive drug delivery technology. Assertio is headquartered in Lake Forest, Illinois, the US.

Scope

- Detailed information on Assertio Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Assertio Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Assertio Therapeutics Inc including a breakdown and examination of key business segments
- Intelligence on Assertio Therapeutics Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Assertio Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Assertio Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Assertio Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Assertio Therapeutics Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Assertio Therapeutics Inc: Company Overview
Assertio Therapeutics Inc: Overview and Key Facts
Assertio Therapeutics Inc: Overview
Assertio Therapeutics Inc: Key Facts
Assertio Therapeutics Inc: Key Employees
Assertio Therapeutics Inc: Key Employee Biographies
Assertio Therapeutics Inc: Major Products and Services
Assertio Therapeutics Inc: Company History
Assertio Therapeutics Inc: Management Statement
Assertio Therapeutics Inc: Locations and Subsidiaries
Assertio Therapeutics Inc: Key Competitors
Assertio Therapeutics Inc: Company Analysis
Assertio Therapeutics Inc: Business Description
Assertio Therapeutics Inc: SWOT Analysis
Assertio Therapeutics Inc: SWOT Overview
Assertio Therapeutics Inc: Strengths
Assertio Therapeutics Inc: Weaknesses
Assertio Therapeutics Inc: Opportunities
Assertio Therapeutics Inc: Threats
Assertio Therapeutics Inc: Corporate Financial Deals Activity
Assertio Therapeutics Inc: Financial Deals Overview
Assertio Therapeutics Inc: Top Deals 2016 – 2020YTD*
Assertio Therapeutics Inc: Advisors
Assertio Therapeutics Inc: Top Legal Advisors
Assertio Therapeutics Inc: Top Financial Advisors
Assertio Therapeutics Inc: Mergers and Acquisitions
Assertio Therapeutics Inc: Partnership
Assertio Therapeutics Inc: Divestments
Assertio Therapeutics Inc: Recent Developments
Assertio Therapeutics Inc: News and Events Summary
Assertio Therapeutics Inc: Business Expansion
Assertio Therapeutics Inc: Corporate Governance
Assertio Therapeutics Inc: Financial Performance
Assertio Therapeutics Inc: Regulatory and Legal Events
Assertio Therapeutics Inc: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Assertio Therapeutics Inc: Key Facts
Table 2: Assertio Therapeutics Inc: Key Employees
Table 3: Assertio Therapeutics Inc: Company History
Table 4: Assertio Therapeutics Inc: Locations and Subsidiaries
Table 5: Assertio Therapeutics Inc: Key Competitors
Table 6: Assertio Therapeutics Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Assertio Therapeutics Inc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Assertio Therapeutics Inc: M&A Average Deal Size - Value (US$m)
Table 9: Assertio Therapeutics Inc: Top Deals 2016 - 2020YTD*
Table 10: Assertio Therapeutics Inc: Legal Advisor Ranking by Value (US$m)
Table 11: Assertio Therapeutics Inc: Financial Advisor Ranking by Value (US$m)
Table 12: Assertio Therapeutics Inc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Assertio Therapeutics Inc: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Assertio Therapeutics Inc: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Assertio Therapeutics Inc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 16: Assertio Therapeutics Inc: News and Events Summary
Table 17: Assertio Therapeutics Inc: Business Expansion
Table 18: Assertio Therapeutics Inc: Corporate Governance
Table 19: Assertio Therapeutics Inc: Financial Performance
Table 20: Assertio Therapeutics Inc: Regulatory and Legal Events
Table 21: Assertio Therapeutics Inc: Research & Development

★海外企業調査レポート[Assertio Therapeutics Inc：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Chagala Group Limited：企業の戦略・SWOT・財務情報
    Chagala Group Limited - Strategy, SWOT and Corporate Finance Report Summary Chagala Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SLEEP NUMBER CORP：企業の戦略・SWOT・財務情報
    SLEEP NUMBER CORP - Strategy, SWOT and Corporate Finance Report Summary SLEEP NUMBER CORP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ono Pharmaceutical Co., Ltd.：企業のM&A・事業提携・投資動向
    Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ono Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Le Chateau Inc. (CTU)：企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Country Club Hospitality & Holidays Ltd.：企業の戦略・SWOT・財務分析
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Guardian Industries Corp.：企業の戦略・SWOT・財務情報
    Guardian Industries Corp. - Strategy, SWOT and Corporate Finance Report Summary Guardian Industries Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Pacific & Orient Berhad：企業の戦略・SWOT・財務分析
    Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report Summary Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SBS Transit Ltd.：企業の戦略・SWOT・財務情報
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ORBCOMM Inc (ORBC)：企業の財務・戦略的SWOT分析
    ORBCOMM Inc (ORBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Astex Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Shinsegae Food Co., Ltd.：企業の戦略・SWOT・財務情報
    Shinsegae Food Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shinsegae Food Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aclaris Therapeutics Inc (ACRS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Aclaris Therapeutics Inc (Aclaris Therapeutics) is a dermatologist-led bio-pharmaceutical company which focuses on identifying, developing, and commercializing prescription drug products for unmet needs in aesthetic and medical dermatology as well as immunology. Its lead product, ESKATA, is …
  • Encompass Health Corp (HLS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Encompass Health Corp (Encompass Health), formerly HealthSouth Corp is a post-acute healthcare service provider that offers rehabilitation and home based patient care services. The center owns and operates inpatient rehabilitation and hospitals and provides treatment to medical conditions su …
  • Hochdorf Holding AG (HOCN)：企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Gibson Energy Inc (GEI)：企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • First Ship Lease Trust (D8DU)：企業の財務・戦略的SWOT分析
    First Ship Lease Trust (D8DU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ID Pharma Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy, and other bio products. It offers vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s ve …
  • Crown Point Energy Inc (CWV)：企業の財務・戦略的SWOT分析
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • Ctrip.com International, Ltd.：企業のM&A・事業提携・投資動向
    Ctrip.com International, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ctrip.com International, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Stora Enso Oyj (STERV)：企業の財務・戦略的SWOT分析
    Stora Enso Oyj (STERV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆